Merrimack Pharmaceuticals
MACK
#7933
Rank
โ‚น19.11 B
Marketcap
โ‚น1,292
Share price
0.00%
Change (1 day)
5.01%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2023 (TTM): -โ‚น9.03

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -โ‚น9.39. In 2022 the company made an earnings per share (EPS) of -โ‚น9.39 an increase over its 2021 EPS that were of -โ‚น15.37.

EPS history for Merrimack Pharmaceuticals from 2010 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น9.03-3.87%
2022-โ‚น9.39-38.89%
2021-โ‚น15.37-25%
2020-โ‚น20.50-81.54%
2019-โ‚น111.03-56.95%
2018-โ‚น257.94-108.5%
2017โ‚น3,033-390.35%
2016-โ‚น1,045-7.35%
2015-โ‚น1,12765%
2014-โ‚น683.27-39.39%
2013-โ‚น1,127-54.01%
2012-โ‚น2,451-53.71%
2011-โ‚น5,29640.37%
2010-โ‚น3,773

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น271.62-2,991.14%๐Ÿ‡ซ๐Ÿ‡ท France
-โ‚น71.74 663.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น29.04 209.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น161.42 1,618.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น481.71 5,027.27%๐Ÿ‡บ๐Ÿ‡ธ USA